Key words: shape change/human erythrocyte/lidocaine/V-ATPase/carboftie anhydrase ABSTRACT. Westudied the mechanism of the lidocaine-induced shape change in humanerythrocytes. Immunohistochemical analysis of erythrocytes using spectrin-specific antibodies revealed aggregation of fluorescence in lidocaine-treated cells, while the fluorescence was distributed diffusely in untreated cells. The intracellular pH in lidocaine-treated erythrocytes was examined by flow cytometry of the cells labeled with 3'-aeetyl-2'-carboxyethyl-6',7'-(dihydropyran-2'-one)-5-carboxyfluorescein diacethoxymethylester (BCECF-AM), and was found to decrease with increasing concentrations of lidocaine. Pre-treatment of erythrocytes with acetazolamide, an inhibitor of carbonic anhydrase, inhibited the lidocaine-induced spectrin aggregation and decrease in intracellular pH. Whenerythrocytes were incubated in medium containing bafilomycin Ai, an inhibitor of V-ATPase, followed by incubation with lidocaine, the cells changed shape slightly and the intracellular pH showed a small decrease in comparison with control. Spectrin dimers extracted from membranesof normal erythrocytes were incubated in buffers of various pHs and analyzed by SDS-PAGE.The amounts of spectrin dimers and tetramers decreased, while that of oligomers increased with decreasing pH. These results suggest that the lidocaine-induced shape change in humanerythrocytes mayoccur by the conformational change of spectrin in a process that may be mediated by carbonic anhydrase and activation of V-ATPase.
ABSTRACT. Westudied the mechanism of the lidocaine-induced shape change in humanerythrocytes. Immunohistochemical analysis of erythrocytes using spectrin-specific antibodies revealed aggregation of fluorescence in lidocaine-treated cells, while the fluorescence was distributed diffusely in untreated cells. The intracellular pH in lidocaine-treated erythrocytes was examined by flow cytometry of the cells labeled with 3'-aeetyl-2'-carboxyethyl-6',7'-(dihydropyran-2'-one)-5-carboxyfluorescein diacethoxymethylester (BCECF-AM), and was found to decrease with increasing concentrations of lidocaine. Pre-treatment of erythrocytes with acetazolamide, an inhibitor of carbonic anhydrase, inhibited the lidocaine-induced spectrin aggregation and decrease in intracellular pH. Whenerythrocytes were incubated in medium containing bafilomycin Ai, an inhibitor of V-ATPase, followed by incubation with lidocaine, the cells changed shape slightly and the intracellular pH showed a small decrease in comparison with control. Spectrin dimers extracted from membranesof normal erythrocytes were incubated in buffers of various pHs and analyzed by SDS-PAGE.The amounts of spectrin dimers and tetramers decreased, while that of oligomers increased with decreasing pH. These results suggest that the lidocaine-induced shape change in humanerythrocytes mayoccur by the conformational change of spectrin in a process that may be mediated by carbonic anhydrase and activation of V-ATPase.
The normal shape of a red blood cell is that of a biconcave discocyte. A variety of amphipathic compounds can cause morphological changes in erythrocytes. Several amphipathic and cationic agents can transform discocytes into stomatocytes, whereas anionic agents can transform discocytes into echinocytes, in a dose-dependent manner (1-4). Sheetz and Singer (5) explained these transformations with the bilayer couple theory, in which cationic, stomatocytic agents are hypothesized to accumulate in the inner leaflet of the plasma membrane,whereas anionic, echinocytic agents concentrate in the outer leaflet. However, conclusive evidence supporting this hypothesis is still lacking. Recently, the mechanism of drug-induced shape changes in erythrocytes has been investigated by examining the asymmetric distribution of phospholipids in the lipid bilayer (4-7). Schrier et al. (4) examined stomatocytosis induced in human red blood cells by vinblastine and chloroplomazine by monitoring the movementsof spinlabeled phosphatidylcholine (PC) and sphingomyelin (SM) by electron spin resonance spectroscopy. They noted an inward shift of approximately %%-\9%of PC and SMin the outer leaflet. In a previous study (8), to investigate the mechanismof drug-induced shape changes in humanerythrocytes, we treated these cells with lidocaine, a cationic drug, and noted that the shape change, which begins after 30 s of treatment, is dependent on lidocaine concentration and incubation time. Furthermore, we found that carbonic anhydrase (CA) and ATP at concentrations more than 0.4 mMin the cytoplasm are required for the shape changes, and that the shape change is related to spectrin, a major componentof the cytoskeleton. In the present study, we investigated the mechanism of the morphological change in human erythrocytes from discocytes to stomatocytes induced by lidocaine in relation to the structural changes in the cytoskeletal protein network and cytoplasmic components. Isolation of spectrin. Spectrin was isolated from the humanerythrocyte membranepreparation as described by Morrow et al. (9) . The membrane extract (15-18 mg of protein) obtained after incubation with 10 volumes of 0.1 mM EDTA(pH8.0) at 4°C for 5h was subjected to Sepharose CL-4B column chromatography (2.5 x 90 cm), and eluted with 10mMTris-HCl, 0.5 mM2-mercaptoethanol, and 0.2 mMdi-isopropylfluorophosphate at a flow rate of 0.6 ml /min.
MATERIALS AND METHODS

Reagents
Observation of changes in shape. The changes in shape of humanerythrocytes were observed by scanning electron microscopy (JEOL, . Specimens were prepared as described previously (8). Erythrocytes were fixed with \% glutaraldehyde in 0.1 M sodium phosphate buffer (pH7.4), followed by alcohol dehydration. Electrophoresis. The protein was electrophoresed by the method of Laemmli (10). Samples were analyzed by SDSPAGEon 3-10% linear gradient gels under nonreducing conditions. Gels were stained with Coomassie brilliant blue R-250, and the intensities of the stained bands were measured using a Personal Densitometer PD1 10 (Molecular Dynamics Co. Ltd., Tokyo, Japan).
Preparation of antibodies against humanerythrocyte spectrin dimers. Tworabbits were immunized by three injections each of mixtures of purified spectrin from human erythrocytes and Freund's adjuvant. The first injection was given subcutaneously with a mixture of 1 mg purified spectrin in 500 (A of PBS and Freund's complete adjuvant (ratio 1 : 1 v/v).
After four weeks, a mixture of 1 mg of purified spectrin in 500 [A of PBS and Freund's incomplete adjuvant (ratio 1 : 1 v/v) was injected intramuscularly. After two more weeks, a final injection was given in the samemanner as the second, and the rabbits were bled two weeks later. Affinity-purified anti-spectrin antibodies were prepared on a columnof purified spectrin-coupled Affigel-10 (Bio Rad) (1 1). Immunofluorescence analysis. Smears of red blood cells (RBCs) were fixed briefly in acetone, washed in PBS and then incubated with a 1 : 20 dilution of primary antiserum in a humid chamber at 37°C for 30min. After rinsing in PBS, the specimens were incubated in FITC-labeled goat antiserum raised against rabbit IgG. A fluorescence microscope was used for immunohistochemical observation.
Measurementof intracellular pH in humanerythrocytes using BCECF-AM. Cytosolic pH was determined using the intracellularly trappable fluorescent pH indicator BCECF-AM(12, 13). Washed human erythrocytes, at a cell density of %%hematocrit, were labeled with 10/iM BCECF-AMin HEPES buffer (153 mMNaCl, 5 mMKC1, 5 mMglucose, 20 mMHEPES pH 7.4) for 60min at 37°C. After incubation, the cells were washed three times with PBSat 2,000xg for 5 min at 4°C. The fluorescence of BCECFwas measured using a FACScan (Becton-Dickinson, Mountain View, CA) flow cytometer at excitation and emission wavelengths of 495 nmand 530 nm, respectively. The pH was calculated by comparing the ratio determined in the sample to a standard curve constructed using cells exposed to high-KCl buffer (130 mMKC1, 10mM NaCl, 1 mMMgSO4, 10mM Na-MOPS) at various A B pHs (pH 6.0, 6.4, 6.7, 7.0, 7.4) for 15 minutes in the presence of 10 ftg/m\ of the ionophore nigericin, which causes equilibration of the intracellular pH with that of the buffer (14). The mean fluorescence was determined by computer analysis of the obtained histograms.
RESULTS
Lidocaine-induced shape change in erythrocytes. Whenerythrocytes were incubated in media containing 0 mM(A) and 15.5 mM (B) lidocaine at 37°C for 5 min, the shape changed from discocytes to stomatocytes (Fig. 1).
Aggregation of spectrin in lidocaine-treated erythrocytes. To examine whether the lidocaine-induced shape change is related directly to spectrin, the distribution of spectrin in lidocaine-treated erythrocytes was observed by indirect immunofluorescence with anti-spectrin antibodies (Fig. 2) . Aggregation of spectrin was observed in lidocaine-treated erythrocytes (Fig. 2B ), while the fluorescence was distributed diffusely in both untreated ( Fig. 2A ) and in combined acetazolamide and lidocaine-treated cells (Fig. 2C) , and in cells washed after treatment with lidocaine (Fig. 2D) . MeasurementofpH in erythrocytes. The intracellular pH of lidocaine-treated and untreated erythrocytes was investigated by flow cytometry. The calibration curve was constructed by obtaining the fluorescence ratios of cells in which intracellular pH was equilibrated with the external buffer pH by the addition of the ionophore nigericin, in the pH range of 6.0-7.4 (Fig. 3) . The fluorescence increased linearly with the increase in pH.
When BCECF-AM-labeled, red cells were incubated with PBS containing 0mM, 1 mM, 5 mM, 10mMand 15mMof lidocaine at 25°C for 5, 15, 30 and 60min, and analyzed by flow cytometry, the fluorescence decreased depending on the concentration of lidocaine for each incubation time (Fig. 4A ). The pH in erythrocytes trobenz-2-oxa-l ,3-diazole (NBD) (19) were used. When erythrocytes were incubated in media containing 10 fiM bafilomycin Al9 1 mMDCCD, 1 mMNEM, and 100 ftM NBDfor 40min, at 37°C, their shape did not change (Fig. 5B , C, D, E). However, on incubation with 21.0 mMlidocaine for 30 min at 37°C after incubation with 10fiM bafilomycin Au 1 mMDCCD, 1 mM NEMand 100fiM NBDfor 10min at 37°C, the shape of erythrocytes changed slightly (Fig. 5B' , C, D' , E' ) in comparison with the lidocaine only-treated cells (Fig.   5A' ). Whenerythrocytes were incubated in mediumcontaining 1 fiM, 5 fiM or 10fiM of bafilomycin A1? 100 fiM9 300ftM9 500fiM and 1 mM DCCD, 100^M, 300 fiM, 500fiM and 1 mMNEM and 50pM, 100fiM and 200fiM NBDfor 5min, 15min, 30min and 60min at 37°C, neither fluorescence nor intracellular pH changed in comparison with the control. In contrast, when erythrocytes were incubated with 14.3 mMlidocaine for 5 min, 15 min, 30 min or 60 min at 37°C after incubation in medium containing 1 //M, 5 fiM or 10 /iM bafilomycinAi, 100/iM, 300/iM, 500fiM or 1 mM DCCD, 100 /iM, 300/iM, 500^M or 1 mM NEM and 50/iM, 100 /iM or 200fiM NBD for 5min, 15min, 30min or 60 min at 37°C, the fluorescence increased with increasing concentrations of inhibitor (Table 1 ; the data for DCCD,NEMand NBDare not shown), and the intracellular pH decreased slightly in comparison with untreated controls (Fig. 6A, B, C, D) . Effect of pH on the extracted spectrin dimers. Whenisolated spectrin dimers were incubated with PBS of various pHs (adjusted with 0.1 M HC1) at 37°C for 20 min and analyzed by SDS-PAGE (Fig. 7A) , the density of the bands of spectrin dimers and tetramers decreased, and that of the high molecular weight spectrin oligomeric species increased with the decrease in pHof the buffer (Fig. 7B) .
DISCUSSION
Westudied the mechanism of the lidocaine-induced shape change of humanerythrocytes from discocytes to stomatocytes. This change in shape begins within 30 s of incubation with lidocaine, is dependent on the incubation period and the concentration of lidocaine, and is reversible (8). Using resealed erythrocyte ghosts, we found that CAand ATPat concentrations in excess of 0.4 mMare required for the shape change (8). Furthermore this shape change was considered to be related to spectrin (8). In the present study, we examined the structural changes of spectrin and the possible roles of carbonic anhydrase and ATPin the lidocaine-induced shape change.
Carbonic anhydrase has been reported to catalyze the reversible hydration of carbon dioxide (CO2+H2OĤ CO3+H+)(20), hydrolysis of certain esters, and various other reactions (21). Lidocaine is a basic tertiary amine and is only marginally soluble in water. Thus, it is usually prepared as its water-soluble salt of lidocaine hydrochloride, where it exists as both uncharged molecules and as positively-charged, substituted ammonium cations. Whenlocal anesthetics in uncharged form pass through the cell membrane, they are assumed to become cationic in the immediate vicinity of nervo-membrane receptors (22, 23) . Since local anesthetics are more effective in blocking action potentials at low rather than high pH (24) , it is likely that they block the action potentials of protonated molecules inside the membrane. Therefore, the pH of lidocaine-treated and erythrocytes incubated with acetazolamide, an inhibitor of carbonic anhydrase (25) , prior to incubation with various concentrations of lidocaine, did not change. ATP has been reported to play various roles in the shape changes of human erythrocytes such as the phosphorylation of spectrin (26) and flip-flop inversion of phospholipids in the membrane (4) (5) (6) (7) 27) . We examined the role of ATPin the lidocaine-induced change in shape related to V-ATPase. Bafilomycin Al9 DCCD, NEMand NBDwere reported previously to inhibit the (18, 19) . When erythrocytes were incubated with lidocaine after incubation in media containing these inhibitors, the shape changed slightly and the intracellular pH decreased slightly in comparison with the lidocaine only-treated cells. It has been reported that a V-ATPaseregulates cytoplasmic pHin murine macrophages (28) . It has been reported that Fig. 6 . Changes in intracellular pH of lidocaine-treated erythrocytes. Erythrocytes were incubated in media containing 0 (A, B, C, D -à"-), 14.3 mMlidocaine (A, B, C, D-#-), 1 fiM bafilomycinAi (A à"à"à"å¡ à"à"à"), 1 j"M bafilomycinAj plus 14.3 mM lidocaine (A-à"-å -à"-), and 300 fiM DCCD (B à"à"à"å¡ à"à"à"), 300fiM DCCD plus 14.3mM lidocaine (B -à"-å --), 300fiM NEM(C à"å à"å¡ à"à"à"), 300fiM NEM plus 14.3mM lidocaine (C --å -), and 100/iM NBD (D à"à"à"å¡ à"à"à"), 100//M NBD plus 14.3mM lidocaine (D --å -à"-) for 5min, 15min, 30min or 60min at 37°C. (Ht<l%) Â^^U^^^^^i^:^:^^s pectrin oligomers à" » ii:"f|-i:mH|P4H^mHRV^' 2 sPectrin tetramers à"à"à"à"fà"#à"à"à"à"^^l^iil^iiSI'rl« Fig. 7 . Analysis by SDS-PAGE(A) and the densities of bands on SDS-PAGEby three-dimensional densitometric analysis (B) of spectrin dimers incubated at 37°C for 30 min in PBS at pH 7.4 (a, a'), 7.0
.7 (e, e' ), 6.6 (f, f), 6.5 (g, g' ), 6.4(h, h' ), 6.3 (i, 0, 6.2 (j, j' ), 6.0 (k, k' ) or 5.5 (1, 1' ). ThepH ofthebuffer was adjusted with 0.1 MHC1. Samples were analyzed on 3-10% linear gradient gels under nonreducing conditions.
cloning and tissue distribution of subunits C, D and E of the human V-ATPase (29) . Although the existence of V-ATPasein human erythrocyte membranes has not been reported, the present results suggest that human erythrocytes possess V-ATPase, and that it was activated by lidocaine, inducing H+ influx and consequently, the observed changes in intracellular pH. The inner side of the red cell membrane is laminated by a twodimensional network of membrane protein which include spectrin, actin and someother components (30) . The majorcomponent of the membrane skeleton is spectrin which is composed of two subunits a and /3. It has beenreported that twospectrin subunits associate noncovalently to form heterodimers which associate head to head to form tetramer and oligomer (31) and further self-assemble into tetramers and oligomers (32) , and that the spectrin dimers-tetramers equilibrium depend on ionic strength, temperature, and spectrin concentration (33) (34) (35) . When the distribution of spectrin in intact cells was analyzed by indirect immunofluorescence, aggregation of fluorescence was observed in the lidocainetreated cells. Conversely, in untreated cells, acetazolamide-treated and PBS-washed lidocaine-treated cells the immunofluorescence was distributed diffusely. The diffuse pattern of fluorescence observed in the latter cells may have been due to the normal ball-shaped spectrin-actin network (36) . The aggregation of fluorescence in the lidocaine-treated cells may indicate aggregation of spectrin. When spectrin dimers isolated from normal erythrocytes were incubated with PBSat various pHs and analyzed by SDS-PAGE, increases in the proportion of spectrin oligomers were observed with decreases in pH.
These data suggest that spectrin aggregation is induced by an acidic intracellular environment in erythrocytes as a result of increases in [H+] caused by lidocaine.
The results of the present study suggest that the lidocaine-induced change in shape of humanerythrocytes is caused by conformational changes in membrane induced by structural change in spectrin, because the multiprotein network associate the spectrin /5 subunit with ankyrin which is itself associated with band 3 (37) .
